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Abstract 
Objectives: To evaluate health-related quality of life (HRQoL) in women with breast
cancer, after surgical intervention, attended at the regional Oncology Referral Hospital in
Juiz de Fora (MG).
Methods: 121 women were evaluated and the European Organization for Research and
Treatment of Cancer, Breast Cancer-Specific Quality of Life Questionnaire (EORTC QLC 30
BR23) was applied.  After the descriptive analysis, a multiple linear regression model was
created. The SPSS 14 was used to build the database and to conduct the analysis.
Results: the mean values of the EORTC QLC 30 BR23 showed a tendency for good
HRQoL, thus, the functional scale showed the most impairment with the worst mean scores
observed. There was statistical significance among the symptoms scale and obese women
who underwent adjuvant radiotherapy and those who had a greater number of dissected
lymph nodes. The subjective perceptions influenced all the EORTC QLC 30 BR23domains.
Conclusions: after controlling the variable by functional hand, and time of surgery, the
BMI variables, breast reconstruction, heavy feeling in the arm, range of motion (ROM) reduc-
tion of the shoulder, and the tight shirt-sleeve sensation proven capable of explaining HRQoL.
HRQoL appears to be relatively good, but negatively influenced by subjective perceptions, in
addition to  treatment factors.
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Introduction
World widely, breast cancer is the most frequent
tumor in women, accounting for 25% of the
neoplasms of this population group in 2012. In
Brazil, around 57,960 women will be diagnosed with
breast cancer in 2016, of which 29,760 will be in the
Southeast alone.1 As one of the main causes of
morbimortality with great epidemiological impor-
tance and relevant  social impact,  becoming  an
important focus for health care.2
In Brazil, failures in screening strategies and
difficulties to access treatment lead to late diagnosis
in advanced tumor stages,2-3 resulting in a more
aggressive surgical approach as the most recom-
mended therapeutic alternative and, consequently, an
increase in the physical, psychological, and social
sequelae.4
The deterioration that the diagnosis and treat-
ment of breast cancer brings to a woman's quality of
life (QoL) has been evident in many studies in recent
years, not only in the context of morbidities, but also
in relation to psychosocial aspects such as the fear of
recurrence or even death, difficulties in carrying on
daily life activities, changes in body image, sexual
dysfunction, and changes in thelifestyle.4
The technological advances for breast cancer in
the diagnosis and treatment have increased the
survival of patients with cancer, that is, adding years
to one's life, but this does not add life to the years,4
thus placing value on a relevant research aspect in
recent times: The quality of life of patients with
breast neoplasia after surgical intervention.5
Although there is no consensus regarding the
definition of the quality of life concept , given the
complexity of variables related to education,
finances, and  sociocultural factors involved, the
authors agree that these three aspects should be
addressed: subjectivity, multidimensionality, and
bipolarity.4 In the health area, therefore, there is a
tendency to recognize the importance of the patient's
point of view in relation to the impact of the illness,
the impairment, and the therapeutic interventions, in
the quality of life context, that is, health-related
quality of life (HRQoL).
Currently, there is a wide variety of generic and
specific instruments for assessing quality of life. The
generic instruments are used for overall assessment
of important aspects related to QoL (physical, social,
psychological, spiritual) in any health condition,
while the specific ones are more sensitive in
detecting changes after an intervention, allowing to
assess  a specific condition of a determined function,
population, or disease. The use of both, generic and
specific, is recommended in order to combine advan-
tages and minimize the disadvantages of each instru-
ment.5 Among the numerous of specific instruments
available for evaluating quality of life related to
breast cancer, the EORTC QLC 30 BR23 stands out
as the most commonly used in the literature,6 as it
has presented proven reproducibility and reliability.7
The city of Juiz de Fora is a reference in the
health area, mainly in oncology, although the quality
of life of women with breast cancer is still unknown
in this city. Therefore, considering the importance of
the topic in the health area, this study intends to
evaluate women’s quality of life of a after surgical
intervention for breast cancer, in order to identify the
potential variables which influence them. The expec-
tation is that the results obtained will help increase
scientific knowledge, enabling the development of
therapies that promote better adaptation to the
disease and to the oncological treatment, and the
actions that minimize the complications arising from
the breast neoplasm treatment, whether they are
physical, social, or psychological.
Methods
This is a cross-sectional, analytical study intended to
assess the quality of life of women with breast
cancer, after surgical intervention, treated at the
regional Oncology Referral Hospital in Juiz de Fora,
Minas Gerais. The information was collected
between January and October 2013.
The study included women in breast cancer treat-
ment after more than six months since surgical inter-
vention, who appeared at the Mastology and
Oncology Outpatient Clinic for follow-up consulta-
tion during the period and at the defined location for
the study. Women with bilateral breast cancer, local-
regional or distant active disease, functional alte-
ration of the upper limbs before the cancer treatment,
and the absence of axillary intervention (partial or
total axillary lymphadenectomy and/or sentinel
lymph node biopsy) were excluded.
After the calculation, according to EpiInfo,
3.5.2®, a minimum of 111 cases was estimated in
order to constitute the study. During the data
collecting phase, 134 women were approached and
invited to participate in this study; 8 did not meet the
inclusion criteria on the interview date; 5 women
refused to participate; thus a total of 121 women
constituted the final sample.
The recruited cases were carried out by
analyzing clinical records of patients who began
breast cancer treatment between January 2007 and
December 2012, at the study location. By analyzing
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the medical records, tumor-related and treatment-
related variables were evaluated.
After identifying the patients meeting the inclu-
sion criteria, they were informed as to the type of
study and how it would be conducted, through the
Informed Consent Form. The study was previously
approved by the Human Research Ethics Committee
at the Federal University of Juiz de Fora, under the
document number 135.887.
The women who agreed to participate in the
study were interviewed by the researcher in charge,
which consisted primarily of a patient profile chart:
identification, sociodemographic data, and surgical
complications. Next, the QoL questionnaire of the
European Organization for Research and Treatment
of Cancer, Breast Cancer-Specific Quality of Life
Questionnaire (EORTC QLC 30 BR-23) was
applied.7
The EORTC - C30, a generic part of the QoL
questionnaire, is multidimensional and aims to
assess the QoL in cancer patients during the previous
two weeks. The first part is composed of 30 items
that address general questions about cancer, such as:
symptoms, side effects of the treatment, psycholo-
gical distress, physical functioning, social interac-
tion, sexuality, body image, overall health, quality of
life, and satisfaction with medical care, regardless to
the type of cancer.
The specific EORTC - BR 23 module aims to
evaluate patients treated for breast cancer or under-
going treatment. This should be used together with
the EORTC - C30. The EORTC-BR 23 scale has 23
questions, with continuity from the general question-
naire, and incorporates the following two scales: the
functional scale, which covers body image and
sexual function; and the symptoms scale, which
focuses on the symptoms of the arm and breast, and
the treatment effects.
Finally, a physical evaluation questionnaire was
applied,  which included the analysis of the presence
of lymphedema, measured according to the Casley-
Smith proposal,8 with the estimated limb volume
being calculated from the five circumference
measurements, treating each segment of the limb as
a pair of circumferences (truncated cone).
The study information was submitted to descrip-
tive analysis to obtain measurements of the central
tendency (mean) and of the dispersion (standard
deviation) for the continuous variables, and the
absolute and relative frequencies for the nominal
variables. The calculations of the mean scores for
each EORTC QLC30 BR23 scale followed the
instructions described in the questionnaire manual.
After the description, the univariate analysis was
performed to test the association between each of the
independent variables and the dependent variable,
QoL. For those that had a normal distribution, the
Student's t-test was used; for the nominal variables,
the chi-square (χ²) was used; and the Mann-Whitney
U test and Kruskal Wallis test for quantitative vari-
ables with non-parametric distribution.
In the multivariate analysis, multiple linear
regression models were constructed for the analysis
of the independent variables associated with the
outcome. The variables with p<0.20 from the
univariate analysis, as well as those with clinical
relevance, controlled for confounding factors (func-
tional hand and time since surgery), were admitted.
The final model admitted variables with p<0.05.
Finally, the Statistical Package for Social Sciences
(SPSS), version 14, was used for the statistical
analysis of the information.
Results
Regarding the sociodemographic characterization of
the evaluated sample, it was verified that 71.1% of
the women were over 50 years of age, with a mean
of 56.99 years (SD = ±10.45). The majority were
white (76%), not married (52.9%), and had
completed at least elementary school (54.5%).
Regarding to occupation, as of the interview date,
71.9% reported being homemakers or retired;
analyzing their occupation before treatment, 73.6%
were included in the labor market (Table 1).
As for the clinical variable BMI, approximately
60.3% of the study population was overweight, with
a mean BMI of 27.36 kg/cm² (SD = ± 5.20) (Table
1).
In relation to the tumor and treatment variables,
conservative breast surgery was the most common
(65.3%), most of the women were diagnosed in
advanced stages III and IV (76%) and had an
average of less than 12 lymph nodes removed
(50.4%). It was observed that 14.9% had done breast
reconstruction and, of these, 88.2% were immediate.
The frequency of adjuvant treatment was high in the
sample, with 81% underwent chemotherapy, 84.3%
underwent radiotherapy, and 86.8% underwent
hormone therapy. About 62% of the women
presented time elapsed between the surgery and the
interview date of over 2 years, with an average of
2.84 years (SD = ±1.54). Regarding the physical
evaluation of the 121 women evaluated, 9 (7.4%)
presented lymphedema in the upper limb homola-
teral to surgical intervention of the breast (Table 1).
The mean values found for each module of the
EORTC 30 and BR 23 questionnaires, a high mean
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Table 1                                                                                                                                                                                                
Description of the study sample according to the variables listed, in women with breast cancer, after surgical
treatment. Juiz de Fora, Minas Gerais, Brazil, 2013.
continue
SLB = sentinel lymph node biopsy; PAD = partial axillary dissection; RAD = radical axillary dissection; BMI = body mass
index.
Notes: Married: with partner or in a stable union; Not married: divorced or separated, widowed or unmarried; Up











































































































Rev. Bras. Saúde Matern. Infant., Recife, 17 (2): 385-399 abr. / jun., 2017 389
Quality of life in women after breast cancer surgery
score of 75.2 (SD = ±22.11) was found on the overall
health scale of the generic EORTC 30 module, indi-
cating a tendency towards a good quality of life. The
functional scale of the EORTC 30 was the most
compromised, with a lower mean score of 28.2 (SD
= ±21.02). In the specific module for breast cancer
(BR23), the symptom scale obtained a low mean
score, 25.7 (SD = ±21.05), indicating a lower
amount of symptoms and a better quality of life.
No statistical significance was observed in the
analysis of the association between the mean scores
of the EORTC QLC30 BR23 and the sociodemo-
graphic variables (Table 2).
Upon comparing the other clinical variables,
tumor, and treatment with the mean scores of the
EORTC QLC 30 and BR 23 scales (Table 3), found
that the clinical variable BMI influenced both
symptom scales of the instrument, with the highest
mean scores (24.8 and 36.7, respectively, with
p=0.029 and p=0.015) observed among obese indi-
viduals, indicating a negative influence of obesity on
quality of life. Radiotherapy showed a significant
association with the EORTC QLC 30 symptom
scale, indicating a poorer quality of life among those
who underwent radiotherapy (p=0.052). In addition,
tangential value was observed between radiotherapy
and the BR23 functional scale, with a better quality
of life observed among those who did not undergo
radiotherapy (p=0.06). In relation to the number of
dissected lymph nodes, there was a significant asso-
ciation with the symptom scale of the specific BR23
module, denoting poorer quality of life among those
with a higher number of lymph nodes removed
(p=0.024). In this study, there were no significant
associations regarding the type of surgery, clinical
stage, axillary lymphadenectomy, chemotherapy,
hormone therapy, and time since surgery in the
EORTC QLC 30 and BR 23 modules (Table 3).
When evaluating the mean scores of the EORTC
QLC 30 and BR 23 modules regarding subjective
perceptions for the diagnosis of lymphedema in rela-
tion to the time elapsed (Table 4), a high significance
was noted in most of the scales (p<0.001), indicating
an influence of the subjective diagnosis of
Table 1                                                                                                                                                                  concluded
Description of the study sample according to the variables listed, in women with breast cancer, after surgical
treatment. Juiz de Fora, Minas Gerais, Brazil, 2013.
SLB = sentinel lymph node biopsy; PAD = partial axillary dissection; RAD = radical axillary dissection; BMI = body mass
index.
Notes: Married: with partner or in a stable union; Not married: divorced or separated, widowed or unmarried; Up
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Table 2                                                                                                                                                                                                                                                         
The relation of the means from the EORTC QLC 30 BR 23 questionnaire scales with the sociodemographic variables, in women with breast cancer, after surgical treatment. Juiz de Fora,
Minas Gerais, Brazil, 2013.
M = mean; SD = standard deviation; p = significance probability.
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Table 3                                                                                                                                                                                                                                                         
The relation of the means from the EORTC QLC 30 BR 23 questionnaire scales with the clinical, tumor and treatment variables, in women with breast cancer, after surgical treatment. Juiz
de Fora, Minas Gerais, Brazil, 2013.
continue
M = mean; SD = standard deviation; p = significance probability.
SLB = sentinel lymph node biopsy; PAD = partial axillary dissection; RAD = radical axillary dissection; BMI = body mass index.
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l.Table 3                                                                                                                                                                                                                                                         concluded                                                                                                                                                                                                                                                       
The relation of the means from the EORTC QLC 30 BR 23 questionnaire scales with the clinical, tumor and treatment variables, in women with breast cancer, after surgical treatment. Juiz
de Fora, Minas Gerais, Brazil, 2013.
M = mean; SD = standard deviation; p = significance probability.
SLB = sentinel lymph node biopsy; PAD = partial axillary dissection; RAD = radical axillary dissection; BMI = body mass index.
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Table 4                                                                                                                                                                                                                                                         
The relation of the mean scores from the EORTC QLC 30 BR23 questionnaire scales with the subjective perceptions for the diagnosis of lymphedema, in relation to the time elapsed after
surgical intervention, in women with breast cancer. Juiz de Fora, Minas Gerais, Brazil, 2013.
continue
M = mean; SD = standard deviation; p = significance probability.
EORTC QLC = European Organization for Research and Treatment of Cancer, Breast Cancer-Specific Quality of Life Questionnaire.
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l.Table 4                                                                                                                                                                                                                                                         concluded                                                                                                                                                                                                                                                       
The relation of the mean scores from the EORTC QLC 30 BR23 questionnaire scales with the subjective perceptions for the diagnosis of lymphedema, in relation to the time elapsed after
surgical intervention, in women with breast cancer. Juiz de Fora, Minas Gerais, Brazil, 2013.
M = mean; SD = standard deviation; p = significance probability.
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Table 5                                                                                                                                                                                                                                                         
Results of the Simple Linear Regression model for the EORTC QLC 30 BR 23 in women treated for breast cancer. Juiz de Fora, Minas Gerais, Brazil, 2013.
BMI = body mass index; NA = not applicable.
EORTC QLC = European Organization for Research and Treatment of Cancer, Breast Cancer-Specific Quality of Life Questionnaire.
BMI
Without breast reconstruction
Heavy feeling in the arm, currently
Reduced hand / elbow movements, currently




















































lymphedema in  the quality of life of this population.
Table 5 shows the variables associated with the
poorer quality of life outcome, which remained in
the final model after controlling for confounding
factors (functional hand and time elapsed since
surgery), according to the instrument's scales: high
BMI (BR23 symptoms, p=0.014), no breast recons-
truction (BR23 functional, p=0.51), heavy feeling in
the arm (overall health, EORTC30 and BR23 symp-
toms, with p values of 0.017, 0.029, and 0.032
respectively), hand and elbow range of motion
reduction (functional and symptoms in both
modules, with p values of <0.001 and 0.014; 0.007
and <0.001, respectively), and a tight shirt-sleeve
sensation at the arm (EORTC 30 and BR23 symp-
toms, with p values of 0.003 and 0.034).
Discussion
Women over 50 years of age, white, with no stable
marital relationship, with a low educational level,
and homemakers or retirees were the main sociode-
mographic characteristics observed in the study
population. Similar characteristics were observed by
other authors in the literature.9-10
According to clinical characteristic, the majority
of the population had a high BMI with a mean of
27.3 kg/m2. Epidemiological studies associated
excess weight and/or obesity, sedentary lifestyle, and
poor eating habits with the increased incidence of
cancer2 and the worst quality of life post-treat-
ment.11
The findings regarding tumor characteristics
show that most of the women were diagnosed in
advanced stages, III and IV. Users of the public
health service have a higher prevalence of advanced
stages, reflecting the longer time between suspected
and confirmed diagnosis, and less frequent
mammography when compared to the private sector.
Consequently, this result  in more invasive
therapy6,12 and reaffirms the deficiencies in inte-
grated actions for cancer control in developing coun-
tries with respect to early detection, effective
screening programs, and timely access to treat-
ment.2-3,13-14
Most of the women underwent axillary
lymphadenectomy and adjuvant therapy. The
majority underwent conservative surgery, in general
not reflecting the surgical approach most commonly
observed in national studies,9-10 which can be
explained by the quality of the information contained
in the medical records and by the methodology used
in the study, which considered only the first surgical
procedure reported in the files.
In this study, health-related quality of life was
assessed as generally good according to the instru-
ment's scales, with the exception of the functional
scale. Other studies corroborated with  these fin-
dings.7,9
Breast cancer patients are at high risk of deve-
loping changes in their physical and psychological
functions, which negatively affect their overall
quality of life. However, the literature indicates that
overall quality of life tends to improve gradually
over time.15 In the present study the mean elapsed
time after surgery was 2.84 years, and according to
Reid-Arndt et al., 16 after three years of treatment the
overall quality of life is similar to  the general popu-
lation. The findings of the present study are in agree-
ment with the literature, indicating high scores for
the quality of life and overall health of women with
breast cancer.7,9
In a general way, adjuvant treatment is related to
a reduced quality of life,9,17 but the negative effects
resulting from systemic treatment are mainly
perceived during treatment due to the appearance of
the symptoms such as pain, fatigue, nausea,
vomiting, and changes in the emotional function,9,18
and tend to progressively improve with time, after
the treatment ends.17 Therefore, the low symptom
score, covered by the EORTC 30 dimension, by the
patients, was expected since they were no longer
under treatment, despite the high frequency of adju-
vant therapy done by these women in our study. In
addition, the low prevalence of lymphedema and
self-reported symptoms of edema and arm pain may
explain the low symptom score from the BR23
module.
It was also observed in the univariate analysis
that only radiotherapy and the extent of axillary
dissection were negatively associated with the
quality of life via the symptoms dimension of the
instrument, as observed in other studies.17
In this study, a negative assessment was shown
from both the QLC30 functional scale, which
focuses on physical, emotional, cognitive, and social
aspects, and the BR23 functional scale, which
addresses body image, sexual function, and future
perspective.
Deficits in emotional, cognitive, and social func-
tion may be persistent to long-term in women with
breast cancer,19 when compared to healthy women.20
In contrast, another study points to better scores via
the SF-36 instrument for the components of mental
and physical health for cancer survivors, compared
to the general population, which can be explained by
the greater appreciation of life upon going through
cancer, as well as by the family support and the care
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received from the health professionals.12
Many studies point to the negative effect on
sexuality, resulting from the treatment, in the quality
of life perceived by women with breast cancer.5,19,21-
22 Problems of lack of sexual interest, vaginal lubri-
cation, and pain at penetration are commonly
reported after chemotherapy treatment17,21 and tend
to worsen over time, with the worst deficits
perceived by younger women.19-20
Alopecia, breast deformities, and the loss of
body symmetry are commonly reported by women
with breast cancer, which imply a negative associa-
tion of body image in QoL.5,21-22 Many studies
affirm that body image is positively related to sexual
satisfaction,19 to the possibility of breast reconstruc-
tion,24-25 and negatively related to depression.17
The breast has a cultural and social meaning in
the experience of female sexuality and any threat to
its integrity is experienced with suffering, causing
feelings of inferiority, rejection, and the loss of sel-
festeem.19,23 Surgical mutilation and the secondary
effects of systemic treatments result in major
psycho-emotional impact in women with breast
cancer, with respect to (re)elaboration of the body
image and sexuality.9 Although breast reconstruction
is beneficial for quality of life, its practice is not a
reality in the public health system, given the low
frequency observed in this study and confirmed in
others.6,9 Since 2013, there has been a legal require-
ment (Law 12.802) for breast reconstructive plastic
surgery in cases of mutilation resulting from cancer.
Total mastectomy is associated with the worst
QoL, when compared to conservative treatment,25
which can be attributed to reduced sexual function19
and more body image problems.24 Breast reconstruc-
tion, when compared to mastectomy without recon-
struction, has better quality of life levels,26 with less
impact on psychological aspects, on sexuality, attrac-
tiveness, and body image.25
Although the analysis of this research cannot
directly associate the scores from the quality of life
subscale with breast reconstruction, another study,
nevertheless, associated sexuality and body image as
a dimension for the positive assessment of health
and quality of life via the BR23 instrument.23 It can
therefore be inferred that the less mutilating sur-
geries, the more quality of life the woman will enjoy,
which was also observed by other authors.9,19,25
Another study, in contrast, affirms that there is no
difference in satisfaction with the surgery and
quality of life among the group of women who
underwent conservative and reconstructive surgery,
evaluated by the SF-36.26
A study evaluating QoL as a function of time
after diagnosis, via the EORTC 30 BR23, demon-
strated a decline in the emotional, social, and sexual
domains of the functional scale, not only in the
period of one to two years after initial treatment, but
also after five years.27 The functional scale of
EORTC 30 BR23 was the only QoL domain that did
not show improvement over time after the initial
diagnosis, with the worst scores being perceived in
body image, sexual function, and future perspective.
This fact is corroborated by a study carried out in
2012,22 in which it was highlighted that body image
has implications for the assessment of health and
quality of life, being a relationship in the opposite
direction, while sexual function and pleasure seem
to be positively related according to the EORTC 30.
Another study, however, found high scores for the
functional scale, which may be explained by the
mean time elapsed after diagnosis (4.8 years) and by
the sample selection, which took place in a public
institution with extensive professional support in the
pre- and post-operative period for this population.7
Regarding clinical variables, high BMI was
broadly associated with quality of life. Obesity is
indicated as a determinant of risk for breast cancer,2
and the presence of physical and metabolic comor-
bidities.27 Studies show positive associations with
weight, more often seen in postmenopausal
women.1,3-4,7,28 Excess weight and lack of physical
activity in this population adversely affect quality of
life and predispose it to worse prognoses for cancer.
In a retrospective study, the prevalence of weight
gain increases over time in women with breast
cancer, after the initial treatment.28 The side effects
of treatment adversely affect physical function, body
weight, and cardiovascular health.28 This impair-
ment tends to negatively affect the performance of
activities of daily life and work, in addition to
compromising healthy life behaviors, such as regular
physical exercise, in these patients.29
With respect to lymphedema, its prevalence after
treatment in this study was 7.4%, lower than that
reported in a previous study carried out at the same
health institution, of 44.8%.10 Although some
authors affirm that size measurement and estimated
limb volume are equally valid instruments with
excellent reproducibility,28 the difference in the
choice of the diagnostic method used to characterize
lymphedema between studies may explain the diver-
gence of the values found. Another factor that may
also explain this difference in prevalence concerns
the follow-up time of the study, since the frequency
of lymphedema tends to increase with the time from
the initial lesion of the axillary lymph nodes via
surgery or radiotherapy.10,29 Thus, the longer the
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follow-up period, the greater the probability of cases
of lymphedema, as verified in the study by Paiva et
al.10 However, the information from the present
study is in agreement with other sectional studies,
which report a frequency between 0% and 22% of
the cases.28
Disagreement between subjective complaints of
lymphedema and the findings upon physical exami-
nation can occur. Although the data from the litera-
ture may be conflicting, the importance of both
methods is not excluded, as subjective patient
complaints may precede the ability to detect objec-
tive changes from lymphedema and minimize its
progression.28
Arm pain, sensation of heaviness, restricted
shoulder amplitude, and edema are symptoms
frequently reported by women with breast cancer
and are commonly associated with the presence of
lymphedema, corroborating results similarly found
in the present study.5,30
Considering that health-related quality of life,
according to the World Health Organization (WHO),
is a multidimensional construct, of a highly subjec-
tive nature and changeable over time, the subjective
perceptions of changes in the upper limb, in this
study, were predictive of negative impact on the of
overall health, physical function (EORTC30 and 23),
and functional (EORTC30 and 23) dimensions of
HRQoL.
Research conducted by Assis et al.30 yielded
results similar to this study, in which complaints of
pain, weakness, numbness, and shoulder range of
motion (ROM) reduction were correlated with
overall health, physical, and functional (EORTC
QLQ-C30 ) dimensions, and body image, upper limb
symptoms, and future perspective (BR23).
After controlling for possible confounding,
breast reconstruction, body mass index (BMI), tight
shirt-sleeve sensation, heavy feeling in the arm, and
shoulder ROM reduction were able to explain
HRQoL, as observed in other stu-
dies.6,9-10,12,15-17,19-20
Although HRQoL is relatively good at six
months after surgical intervention, subjective
perceptions have proven to be predictors of greater
negative influence for women with breast neoplasia,
in addition to factors such as BMI and breast recons-
truction.
Another interesting aspect of this study lies in
the implications its results may have for the deve-
lopment of therapies promoting better adaptation to
the disease and to cancer treatment. Thus, such
knowledge can contribute to the production of inte-
gral care for breast cancer patients through health
team follow-up protocols in the pre- and post-opera-
tive period, in order to prevent, reduce, or minimize
functional alterations, social disability, and to
promote the psychosocial well-being of these
women.
It should be noted that the absence of a cut-off
point for the study population in the EORTC QLC
30 BR23 instruments used makes it difficult to esta-
blish more precise assessments, and limits compara-
bility and extrapolation of the results. The absence
of a prior evaluation of the BMI and the measure-
ment of the volume of the affected arm is another
limitation of the study. In order to meet these
demands, further studies must be carried out.
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